Disc Medicine reported net income of -$59.53M for the quarter ended Jun 2026. This income statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 4.31M | 4.32M | 4.32M | 4.32M | 4.33M | 1.04M | 19.58M | 22.85M | 24.14M | 24.36M | 24.70M | 29.71M | 29.75M | 29.87M | 34.58M | 34.69M | 35.01M | 37.89M | 38.19M | 38.35M | ||||||
| Operating items | ||||||||||||||||||||||||||
| Research & DevelopmentR&D | 13.46M | -10.91M | 7.82M | 7.71M | 7.89M | 10.02M | 20.18M | 12.10M | 14.42M | 22.57M | 23.70M | 23.48M | 24.68M | 24.80M | 27.76M | 46.32M | 50.33M | 46.22M | 45.90M | 46.93M | ||||||
| Selling, General & AdministrativeSG&A | 5.00M | -9.41M | 2.14M | 4.30M | 2.59M | 5.00M | 4.95M | 5.23M | 4.54M | 7.15M | 7.76M | 7.37M | 8.17M | 9.75M | 12.18M | 15.09M | 17.36M | 20.75M | 23.62M | 18.14M | ||||||
| Other Operating ExpensesOther Opex | ||||||||||||||||||||||||||
| Operating ExpensesOpex | 18.45M | -20.33M | 9.96M | 12.02M | 10.48M | 15.02M | 25.12M | 17.33M | 18.96M | 29.71M | 31.46M | 30.85M | 32.86M | 34.55M | 39.95M | 61.41M | 67.70M | 66.97M | 69.52M | 65.08M | ||||||
| Operating IncomeOp. Inc | -18.45M | 20.33M | -9.96M | -12.02M | -10.48M | -15.02M | -25.12M | -17.33M | -18.96M | -29.71M | -31.46M | -30.85M | -32.86M | -34.55M | -39.95M | -61.41M | -67.70M | -66.97M | -69.52M | -65.08M | ||||||
| EBIT | -18.45M | 20.33M | -9.96M | -12.02M | -10.48M | -15.02M | -25.12M | -17.33M | -18.96M | -29.71M | -31.46M | -30.85M | -32.86M | -34.55M | -39.95M | -61.41M | -67.70M | -66.97M | -69.52M | -65.08M | ||||||
| Non-operating items | ||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.10M | 0.09M | 0.07M | 0.05M | 0.04M | 0.57M | 0.90M | 0.91M | 0.92M | 0.88M | 0.84M | 0.91M | ||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.01M | 0.00M | 0.01M | 0.04M | 0.27M | 0.39M | 2.37M | 2.91M | 4.84M | 4.68M | 4.52M | 4.57M | 6.36M | 5.84M | 6.88M | 7.06M | 6.41M | 7.41M | 6.89M | 6.53M | ||||||
| Other Non Operating IncomeOther Non Op Inc. | -5.05M | 0.10M | 2.39M | -5.94M | 3.39M | -0.01M | 0.01M | -0.01M | -0.00M | -0.01M | 0.01M | 0.00M | -0.00M | 0.07M | -0.02M | 12.98M | 0.02M | -0.01M | ||||||||
| Non Operating IncomeNon Op. Inc. | 0.11M | 2.44M | -5.67M | 3.78M | 2.37M | 1.41M | 4.86M | 6.17M | 4.52M | 4.56M | 6.37M | 5.27M | 5.98M | 6.21M | 5.48M | 6.53M | 6.07M | 5.61M | ||||||||
| Net income details | ||||||||||||||||||||||||||
| EBT | -18.55M | 20.25M | -9.85M | -9.58M | -16.15M | -11.24M | -22.76M | -15.92M | -14.10M | -23.55M | -26.94M | -26.29M | -26.48M | -29.28M | -33.97M | -55.20M | -62.22M | -60.77M | -63.45M | -59.46M | ||||||
| Tax ProvisionsTaxes | 0.10M | -0.00M | 0.10M | 0.06M | 0.11M | 0.15M | 0.12M | 0.05M | 0.10M | -44.76M | 0.10M | 0.07M | ||||||||||||||
| Profit After TaxPAT | -18.55M | 18.08M | -9.85M | -9.58M | -16.15M | -11.24M | -22.78M | -15.95M | -14.12M | -23.58M | -26.95M | -26.35M | -26.60M | -29.46M | -34.09M | -55.25M | -62.32M | -60.53M | -63.50M | -59.53M | ||||||
| Income from Continuing OperationsIncome (Continuing) | -18.55M | 20.25M | -9.85M | -9.58M | -16.15M | -11.24M | -22.86M | -15.92M | -14.10M | -23.55M | -27.04M | -26.35M | -26.60M | -29.44M | -34.09M | -55.25M | -62.32M | -16.02M | -63.55M | -59.53M | ||||||
| Consolidated Net IncomeConsol Net Inc. | -18.55M | 20.25M | -9.85M | -9.58M | -16.15M | -11.24M | -22.86M | -15.92M | -14.10M | -23.55M | -27.04M | -26.35M | -26.60M | -29.44M | -34.09M | -55.25M | -62.32M | -16.02M | -63.55M | -59.53M | ||||||
| Income towards Parent CompanyParent Net Inc | -18.55M | 20.25M | -9.85M | -9.58M | -16.15M | -11.24M | -22.86M | -15.92M | -14.10M | -23.55M | -27.04M | -26.35M | -26.60M | -29.44M | -34.09M | -55.25M | -62.32M | -16.02M | -63.55M | -59.53M | ||||||
| Net Income towards Common StockholdersNet Income | -18.55M | 20.25M | -9.85M | -9.58M | -16.15M | -11.24M | -22.78M | -15.95M | -14.12M | -23.58M | -26.95M | -26.35M | -26.60M | -29.44M | -34.09M | -55.25M | -62.32M | -16.02M | -63.55M | -59.53M | ||||||
| Additional items | ||||||||||||||||||||||||||
| EPS (Basic) | -4.30 | 5.02 | -2.28 | -2.22 | -3.73 | -10.82 | -1.20 | -0.74 | -0.58 | -1.06 | -1.09 | -1.03 | -0.89 | -1.07 | -1.02 | -1.58 | -1.77 | -0.45 | -1.65 | -1.54 | ||||||
| EPS (Diluted) | -4.30 | 23.05 | -10.67 | -2.22 | -3.73 | -10.82 | -1.20 | -0.74 | -0.58 | -1.06 | -1.09 | -1.03 | -0.89 | -1.07 | -1.02 | -1.58 | -1.77 | -0.45 | -1.65 | -1.54 | ||||||
| Shares Outstanding | 4.31M | 4.04M | 4.32M | 4.32M | 4.33M | 1.04M | 18.95M | 21.48M | 24.32M | 22.32M | 24.81M | 25.65M | 29.94M | 27.61M | 33.32M | 35.02M | 35.18M | 35.30M | 38.49M | 38.69M | ||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 4.31M | 0.88M | 0.92M | 4.32M | 4.33M | 1.04M | 18.95M | 21.48M | 24.32M | 22.32M | 24.81M | 25.65M | 29.94M | 27.61M | 33.32M | 35.02M | 35.18M | 35.30M | 38.49M | 38.69M | ||||||
| EBITDA | -18.45M | 20.33M | -9.96M | -12.02M | -10.48M | -15.02M | -25.12M | -17.33M | -18.96M | -29.71M | -31.46M | -30.85M | -32.86M | -34.55M | -39.95M | -61.41M | -67.70M | -66.97M | -69.52M | -65.08M | ||||||
| Interest ExpensesInt Expense | 0.10M | 0.09M | 0.07M | 0.05M | 0.04M | 0.57M | 0.90M | 0.91M | 0.92M | 0.88M | 0.84M | 0.91M | ||||||||||||||
| Tax Rate | -0.44 | 0.00 | -0.37 | -0.23 | -0.43 | -0.53 | -0.35 | -0.09 | -0.16 | 73.65 | -0.16 | -0.12 |